Resmed Inc. buy Royal Bank of Canada
Start price
15.07.25
/
50%
€220.80
Target price
15.07.26
€251.96
Performance (%)
-2.94%
Price
15:45
€214.30
Summary
This prediction is currently active. With a performance of -2.94%, the BUY prediction for Resmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 15.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.019% | -1.019% |
| iShares Core DAX® | 0.024% | 0.583% |
| iShares Nasdaq 100 | 1.740% | -2.061% |
| iShares Nikkei 225® | 0.428% | 10.487% |
| iShares S&P 500 | 1.329% | 0.140% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat